These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33234727)

  • 1. Downregulation of enhancer RNA EMX2OS is associated with poor prognosis in kidney renal clear cell carcinoma.
    Jiang H; Chen H; Wan P; Song S; Chen N
    Aging (Albany NY); 2020 Nov; 12(24):25865-25877. PubMed ID: 33234727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EMX2OS plays a prognosis-associated enhancer RNA role in gastric cancer.
    Liu GX; Tan YZ; He GC; Zhang QL; Liu P
    Medicine (Baltimore); 2021 Oct; 100(41):e27535. PubMed ID: 34731149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma.
    Song J; Peng J; Zhu C; Bai G; Liu Y; Zhu J; Liu J
    Cell Physiol Biochem; 2018; 48(6):2549-2562. PubMed ID: 30121668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC00997, a novel long noncoding RNA, contributes to metastasis via regulation of S100A11 in kidney renal clear cell carcinoma.
    Chang Y; Li N; Yuan W; Wang G; Wen J
    Int J Biochem Cell Biol; 2019 Nov; 116():105590. PubMed ID: 31442606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of enhancer RNA AC003092.1 is associated with poor prognosis in kidney renal clear cell carcinoma.
    Li J; Gan J; Chen C; Yuan Y; Xiong X; Li L; Luo P; Zhang W
    Sci Rep; 2024 Jun; 14(1):13475. PubMed ID: 38866983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The downregulation of lncRNA EMX2OS might independently predict shorter recurrence-free survival of classical papillary thyroid cancer.
    Gu Y; Feng C; Liu T; Zhang B; Yang L
    PLoS One; 2018; 13(12):e0209338. PubMed ID: 30576338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
    Yu J; Mao W; Xu B; Chen M
    Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation expression and prognostic significance of Syntaxin4 in kidney renal clear cell carcinoma.
    He L; Jiang H; Lai Z; Zhong Z; Huang Z
    BMC Cancer; 2021 Sep; 21(1):992. PubMed ID: 34482824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of CCL5 on the immune cells infiltration and the prognosis of patients with kidney renal clear cell carcinoma.
    Bai S; Wu Y; Yan Y; Kang H; Zhang J; Ma W; Gao Y; Hui B; Li R; Zhang X; Ren J
    Int J Med Sci; 2020; 17(18):2917-2925. PubMed ID: 33173412
    [No Abstract]   [Full Text] [Related]  

  • 10. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
    Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
    J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.
    Han G; Zhao W; Song X; Kwok-Shing Ng P; Karam JA; Jonasch E; Mills GB; Zhao Z; Ding Z; Jia P
    BMC Genomics; 2017 Oct; 18(Suppl 6):678. PubMed ID: 28984208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of long non-coding RNA NBAT-1 is associated with poor prognosis in patients with clear cell renal cell carcinoma.
    Xue S; Li QW; Che JP; Guo Y; Yang FQ; Zheng JH
    Int J Clin Exp Pathol; 2015; 8(4):3765-74. PubMed ID: 26097558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
    Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH
    Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune associated LncRNAs identify novel prognostic subtypes of renal clear cell carcinoma.
    Khadirnaikar S; Kumar P; Pandi SN; Malik R; Dhanasekaran SM; Shukla SK
    Mol Carcinog; 2019 Apr; 58(4):544-553. PubMed ID: 30520148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NR1B2 suppress kidney renal clear cell carcinoma (KIRC) progression by regulation of LATS 1/2-YAP signaling.
    Yin L; Li W; Wang G; Shi H; Wang K; Yang H; Peng B
    J Exp Clin Cancer Res; 2019 Aug; 38(1):343. PubMed ID: 31391070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of METTL14 in Kidney Renal Clear Cell Carcinoma Using Bioinformatics Analysis.
    Wang Q; Zhang H; Chen Q; Wan Z; Gao X; Qian W
    Dis Markers; 2019; 2019():5648783. PubMed ID: 31976022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of long non-coding RNAs in clear cell renal cell carcinoma: A meta-analysis.
    Wang Y; Li Z; Li W; Zhou L; Jiang Y
    Medicine (Baltimore); 2019 Oct; 98(40):e17276. PubMed ID: 31577719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A long non-coding RNA signature to improve prognostic prediction in clear cell renal cell carcinoma.
    Zhang J; Zhang X; Piao C; Bi J; Zhang Z; Li Z; Kong C
    Biomed Pharmacother; 2019 Oct; 118():109079. PubMed ID: 31351427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of long non-coding RNA ENSG00000241684 is associated with poor prognosis in advanced clear cell renal cell carcinoma.
    Su H; Wang H; Shi G; Zhang H; Sun F; Ye D
    Eur J Surg Oncol; 2018 Jun; 44(6):840-846. PubMed ID: 29433989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy-related gene
    Xie L; Li H; Zhang L; Ma X; Dang Y; Guo J; Liu J; Ge L; Nan F; Dong H; Yan Z; Guo X
    Aging (Albany NY); 2020 Jan; 12(2):1828-1842. PubMed ID: 32003756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.